
Making history, defining the future Elekta offers the world’s most complete portfolio of stereotactic treatment solutions for the treatment of cancer and diseases of the brain, spine and body. The resulting systems’ design and performance reflect decades of leadership and innovation*. Our radiation oncology and neurosurgery customers face the constant cost-benefit challenge of wanting to adopt the most advanced treatment protocols within the constraints of the resources available. Elekta Axesse™ has been specifically developed to help meet this challenge, to bring the highest treatment quality to the maximum number of patients. | | Resource management benefitsCaseload versatility Workflow efficiency Patient throughput Treatment quality benefitsPatient safety Targeting accuracy Dose escalation Hypofractionation A wide range of stereotactic and intensity modulated treatmentsLung Liver Prostate Head-and-neck Spinal metastases Large brain metastases Click to download a complete copy of the Elekta Axesse brochure - Control without compromise. * Elekta developed the field of intracranial stereotactic radiosurgery (First Leksell GammaKnife® introduced 1968); introduced stereotactic body radiation therapy (Stereotactic Body Frame® launched 1991; and pioneered intensity modulated radiation therapy and image guided radiation therapy (Elekta Synergy® in clinical use since 2003). | |